Ani Pharmaceuticals ANIP
NASDAQ ANIP
$70.70 +0.47 (+0.67%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ani Pharmaceuticals (ANIP) Tax Rate Growth (3y) (2015 - 2026)

Analysis

Ani Pharmaceuticals (ANIP) Tax Rate Growth (3y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,248.00
Mar 31, 2026 -632.00
Dec 31, 2025 -1,309.00
Sep 30, 2025 -833.00
Jun 30, 2025 -172.00
Mar 31, 2025 -85.00
Dec 31, 2024 356.00
Sep 30, 2024 -1,459.00
Mar 31, 2024 3,813.00
Dec 31, 2023 3,108.00
Sep 30, 2023 64,882.00
Jun 30, 2023 -2,951.00
Mar 31, 2023 371.00
Dec 31, 2022 -1,117.00
Sep 30, 2022 2,804.00
Jun 30, 2022 3,173.00
Mar 31, 2022 -2,870.00
Dec 31, 2021 -425.00
Sep 30, 2021 1,699.00
Jun 30, 2021 150.00